URSOAID 300

(Ursodeoxycholic Acid 300 mg)

Hepatobiliary Protection in Metabolic & Renal Patients

PRODUCT INTRODUCTION

Brand Name: URSOAID 300
Composition: Ursodeoxycholic Acid (UDCA) 300 mg

Category: Hepatoprotective / Bile Acid Therapy

 CLINICAL BACKGROUND

In metabolic and CKD patients:

• Fatty liver common
• Cholestasis may occur
• Drug-induced liver dysfunction
• Gallstone risk increases
• Elevated liver enzymes seen frequently

👉 UDCA improves bile flow and protects hepatocytes.

 MODE OF ACTION (MOA)

• Hydrophilic bile acid
• Replaces toxic hydrophobic bile acids
• Improves bile secretion
• Stabilizes hepatocyte membrane
• Reduces cholestasis

 

Clinical Effects:

✔ Improves LFT levels
✔ Dissolves cholesterol gallstones
✔ Reduces pruritus in cholestasis
✔ Protects liver in metabolic disorders

 INDICATIONS

• Non-alcoholic fatty liver disease (NAFLD)
• Cholestatic liver disease
• Gallstones (cholesterol type)
• Elevated liver enzymes
• Drug-induced hepatotoxicity support
• Adjunct in metabolic syndrome patients

 DOSAGE

• 300 mg once or twice daily
• Dose based on body weight & indication
• As prescribed by physician

 FEATURE – ADVANTAGE – BENEFIT (FAB)

🔹 Feature

Hydrophilic bile acid therapy

🔹 Advantage

Replaces toxic bile acids & improves bile flow

🔹 Benefit

Improved liver function & reduced hepatic stress

 USP

✔ Improves cholestasis
✔ Liver enzyme normalization support
✔ Useful in fatty liver patients
✔ Safe long-term therapy
✔ Metabolic segment positioning

 

 SAFETY PROFILE

• Mild diarrhea possible
• Rare abdominal discomfort
• Generally well tolerated
• Monitor LFTs periodically